76 related articles for article (PubMed ID: 22498098)
1. Serum and CSF measles antibody levels increase over time in patients with multiple sclerosis or clinically isolated syndrome.
Ahlgren C; Odén A; Bergström T; Lycke J
J Neuroimmunol; 2012 Jun; 247(1-2):70-4. PubMed ID: 22498098
[TBL] [Abstract][Full Text] [Related]
2. The effect of live, attenuated measles vaccine and measles infection on measles antibody levels in serum and CSF of patients with multiple sclerosis or clinically isolated syndrome.
Ahlgren C; Odén A; Haghighi S; Andersen O; Bergström T; Lycke J
J Neuroimmunol; 2011 Jun; 235(1-2):98-103. PubMed ID: 21550125
[TBL] [Abstract][Full Text] [Related]
3. Novel cerebrospinal fluid and serum autoantibody targets for clinically isolated syndrome.
Rouwette M; Somers K; Govarts C; De Deyn PP; Hupperts R; Van Wijmeersch B; De Jong BA; Verbeek MM; Van Pesch V; Sindic C; Villar LM; Álvarez-Cermeño JC; Stinissen P; Somers V
J Neurochem; 2012 Nov; 123(4):568-77. PubMed ID: 22958230
[TBL] [Abstract][Full Text] [Related]
4. Serum and cerebrospinal fluid light neurofilaments and antibodies against them in clinically isolated syndrome and multiple sclerosis.
Fialová L; Bartos A; Svarcová J; Zimova D; Kotoucova J; Malbohan I
J Neuroimmunol; 2013 Sep; 262(1-2):113-20. PubMed ID: 23870535
[TBL] [Abstract][Full Text] [Related]
5. The intrathecal, polyspecific antiviral immune response: Specific for MS or a general marker of CNS autoimmunity?
Jarius S; Eichhorn P; Jacobi C; Wildemann B; Wick M; Voltz R
J Neurol Sci; 2009 May; 280(1-2):98-100. PubMed ID: 19041103
[TBL] [Abstract][Full Text] [Related]
6. Intrathecal EBV antibodies are part of the polyspecific immune response in multiple sclerosis.
Otto C; Oltmann A; Stein A; Frenzel K; Schroeter J; Habbel P; Gärtner B; Hofmann J; Ruprecht K
Neurology; 2011 Apr; 76(15):1316-21. PubMed ID: 21482946
[TBL] [Abstract][Full Text] [Related]
7. Cells producing antibody to measles and herpes simplex virus in cerebrospinal fluid and blood of patients with multiple sclerosis and controls.
Baig S; Olsson O; Olsson T; Löve A; Jeansson S; Link H
Clin Exp Immunol; 1989 Dec; 78(3):390-5. PubMed ID: 2558823
[TBL] [Abstract][Full Text] [Related]
8. Temporal dynamics of anti-MOG antibodies in CNS demyelinating diseases.
Di Pauli F; Mader S; Rostasy K; Schanda K; Bajer-Kornek B; Ehling R; Deisenhammer F; Reindl M; Berger T
Clin Immunol; 2011 Mar; 138(3):247-54. PubMed ID: 21169067
[TBL] [Abstract][Full Text] [Related]
9. CSF proteome analysis in clinically isolated syndrome (CIS): candidate markers for conversion to definite multiple sclerosis.
Tumani H; Lehmensiek V; Rau D; Guttmann I; Tauscher G; Mogel H; Palm C; Hirt V; Suessmuth SD; Sapunova-Meier I; Ludolph AC; Brettschneider J
Neurosci Lett; 2009 Mar; 452(2):214-7. PubMed ID: 19383442
[TBL] [Abstract][Full Text] [Related]
10. Intrathecal polyspecific immune response to neurotropic viruses in multiple sclerosis: a comparative report from Cuban patients.
Robinson-Agramonte M; Reiber H; Cabrera-Gomez JA; Galvizu R
Acta Neurol Scand; 2007 May; 115(5):312-8. PubMed ID: 17489941
[TBL] [Abstract][Full Text] [Related]
11. Quantitation of intrathecal antibodies in cerebrospinal fluid of subacute sclerosing panencephalitis, herpes simplex encephalitis and multiple sclerosis: discrimination between microorganism-driven and polyspecific immune response.
Jacobi C; Lange P; Reiber H
J Neuroimmunol; 2007 Jul; 187(1-2):139-46. PubMed ID: 17512988
[TBL] [Abstract][Full Text] [Related]
12. Serum measles antibodies in multiple sclerosis.
Cendrowski W; Polna I; Niedzielska K
J Neurol Neurosurg Psychiatry; 1973 Feb; 36(1):57-60. PubMed ID: 4691691
[TBL] [Abstract][Full Text] [Related]
13. Tau protein, phosphorylated tau protein and beta-amyloid42 in the cerebrospinal fluid of multiple sclerosis patients.
Valis M; Talab R; Stourac P; Andrys C; Masopust J
Neuro Endocrinol Lett; 2008 Dec; 29(6):971-6. PubMed ID: 19112391
[TBL] [Abstract][Full Text] [Related]
14. Paediatric and adult multiple sclerosis: age-related differences and time course of the neuroimmunological response in cerebrospinal fluid.
Reiber H; Teut M; Pohl D; Rostasy KM; Hanefeld F
Mult Scler; 2009 Dec; 15(12):1466-80. PubMed ID: 19995844
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of viral antibodies in Iranian multiple sclerosis patients.
Khaki M; Ghazavi A; Ghasami K; Rafiei M; Payani MA; Ghaznavi-Rad E; Mosayebi G
Neurosciences (Riyadh); 2011 Jul; 16(3):224-8. PubMed ID: 21677611
[TBL] [Abstract][Full Text] [Related]
16. Serum and cerebrospinal fluid prolactin levels in male and female patients with clinically-isolated syndrome or relapsing-remitting multiple sclerosis.
Markianos M; Koutsis G; Evangelopoulos ME; Mandellos D; Sfagos C
J Neuroendocrinol; 2010 Jun; 22(6):503-8. PubMed ID: 20236233
[TBL] [Abstract][Full Text] [Related]
17. Multiple sclerosis: subclasses of intrathecally synthesized IgG and measles and varicella zoster virus IgG antibodies.
Vartdal F; Vandvik B
Clin Exp Immunol; 1983 Dec; 54(3):641-7. PubMed ID: 6317243
[TBL] [Abstract][Full Text] [Related]
18. Detection of virus-specific intrathecally synthesised immunoglobulin G with a fully automated enzyme immunoassay system.
Schubert J; Weissbrich B
BMC Neurol; 2007 May; 7():12. PubMed ID: 17535416
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus-specific antibody response in cerebrospinal fluid and serum of patients with multiple sclerosis.
Castellazzi M; Tamborino C; Cani A; Negri E; Baldi E; Seraceni S; Tola MR; Granieri E; Contini C; Fainardi E
Mult Scler; 2010 Jul; 16(7):883-7. PubMed ID: 20483883
[TBL] [Abstract][Full Text] [Related]
20. [Neurofilament protein light in multiple sclerosis].
Zhang Y; Li X; Qiao J
Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2745-9. PubMed ID: 18167263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
